EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Multiomics Analysis Identifies HK2 as a Key Regulator of Metabolic Reprogramming in Hepatic Stellate Cells

Lu Han iD, Fan Lu iD, Shaojie Chen iD, Qingxiu Zhang iD, Huayue Wu iD, Tao Huang iD, Hongfei Pu iD, Jinglin Wang iD, Gaoliang Zou iD, Chen Pan iD, Xueke Zhao iD

Human Mutation · 2025

DOI: 10.1155/humu/1584910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2025. Verfasst von Lu Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Liver Cirrhosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver damage caused by chronic liver disease frequently leads to hepatic fibrosis. A pivotal step in the fibrotic process is the activation of hepatic stellate cells (HSCs). Previous studies have suggested that enhanced aerobic glycolysis is closely associated with HSC activation. However, a comprehensive analysis of the relationship between hepatic fibrosis and aerobic glycolysis remains lacking.

Methods

RNA sequencing of liver tissue from 30 patients with fibrosis or cirrhosis and 8 healthy controls was conducted as part of a comprehensive multiomics approach to discover differentially expressed genes (DEGs). Weighted gene coexpression network analysis (WGCNA) was conducted to detect gene modules associated with liver fibrosis. Functional analyses, including migration and wound healing, were subsequently performed. Furthermore, a machine learning model predicting fibrosis was constructed based on glycolysis‐related gene expression and validated using an independent dataset. Its clinical significance was subsequently explored. Protein expression and localization were further validated via western blotting and immunohistochemistry techniques.

Results

The expression of HK2 is notably increased in HSCs and is strongly linked to the advancement of liver fibrosis. Within the constructed machine learning model, the random forest algorithm demonstrated the highest predictive performance for liver fibrosis, achieving an area under the curve (AUC) of 0.889. HK2 expression levels also had a positive correlation with clinical signs of liver damage, such as ALT and AST levels. Knockdown of HK2 in HSCs markedly impaired their migratory capacity and wound healing ability.

Conclusions

HK2 is involved in activating HSCs, thus promoting the progression of liver fibrosis. These findings suggest that HK2 holds potential as a therapeutic target for liver fibrosis and as a biomarker for predicting its progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsLiver CirrhosisHumansMaleGene Regulatory NetworksFemaleMachine LearningCell MovementGlycolysisGene Expression ProfilingMiddle AgedComputational BiologyMetabolic ReprogrammingMultiomics

Stichwörter der Autor:innen

HK2RNA sequencingWGCNAaerobic glycolysishepatic stellate cellsliver fibrosissingle-cell sequencingtherapeutic target

Autor:innen und Institutionen

  • Department of Infectious Diseases, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Comprehensive Ward, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Obstetrics, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Critical Care Medicine, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
  • Department of Gastroenterology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.

ORCID-Profile: Lu Han, Fan Lu, Shaojie Chen, Qingxiu Zhang, Huayue Wu, Tao Huang, Hongfei Pu, Jinglin Wang, Gaoliang Zou, Chen Pan, Xueke Zhao

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Program of Guizhou Province

Zitieren

APA

Han, L., Lu, F., Chen, S., Zhang, Q., Wu, H., Huang, T., Pu, H., Wang, J., Zou, G., Pan, C., & Zhao, X. (2025). Integrative Multiomics Analysis Identifies HK2 as a Key Regulator of Metabolic Reprogramming in Hepatic Stellate Cells. Human Mutation. https://doi.org/10.1155/humu/1584910

Vancouver

Han L, Lu F, Chen S, Zhang Q, Wu H, Huang T, et al. Integrative Multiomics Analysis Identifies HK2 as a Key Regulator of Metabolic Reprogramming in Hepatic Stellate Cells. Human Mutation. 2025. doi:10.1155/humu/1584910

BibTeX
@article{Han2025,
  author = {Han, Lu and Lu, Fan and Chen, Shaojie and Zhang, Qingxiu and Wu, Huayue and Huang, Tao and Pu, Hongfei and Wang, Jinglin and Zou, Gaoliang and Pan, Chen and Zhao, Xueke},
  title = {Integrative Multiomics Analysis Identifies HK2 as a Key Regulator of Metabolic Reprogramming in Hepatic Stellate Cells},
  journal = {Human Mutation},
  year = {2025},
  doi = {10.1155/humu/1584910}
}
Kostenlos starten →